GlassScriptPhysician profile
Chad Sila
NPI 1477744811
$3,216.90
in general payments reported to CMS, 2019-2025
27 companies · $79.96 in 2025
The $79.96 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,102 · 2020: $127 · 2021: $195 · 2022: $277 · 2023: $521 · 2024: $915 · 2025: $79.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $109.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $671.02 | 2023-2024 | Halcyon, Truebeam |
| Boston Scientific Corporation | $611.96 | 2019 | |
| Myriad Genetic Laboratories, INC. | $284.09 | 2022-2023 | Prolaris |
| Sumitomo Pharma America, INC. | $199.22 | 2023-2025 | Orgovyx |
| Exelixis INC. | $168.58 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $153.62 | 2019-2020 | |
| Teleflex LLC | $151.88 | 2024-2025 | Barrigel |
| Regeneron Healthcare Solutions, INC. | $146.80 | 2019-2023 | Libtayo |
| Medtec LLC | $108.00 | 2021 | |
| Covidien LP | $77.00 | 2019 | |
| Ge Healthcare | $75.72 | 2024 | |
| Depuy Synthes Sales INC. | $65.83 | 2021 | |
| Eisai INC. | $65.17 | 2019 | |
| Stemline Therapeutics INC. | $60.61 | 2019-2020 | |
| Elekta, INC. | $57.22 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $45.10 | 2019 | |
| Intuitive Surgical, INC. | $43.53 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.48 | 2019-2022 | |
| Amgen INC. | $30.46 | 2019 | |
| Bioprotect Medical, INC. | $27.67 | 2025 | Bioprotect Balloon Implant System |
| Telix Pharmaceuticals | $27.43 | 2024 | Illuccix |
| Progenics Pharmaceuticals, INC. | $22.58 | 2023 | Pylarify |
| Myovant Sciences INC. | $21.36 | 2021 | |
| Tactile Systems Technology INC | $17.44 | 2022 | |
| Taiho Oncology, INC. | $16.18 | 2019 | |
| Varian Medical Systems, INC. | $15.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Sila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.